Purpose To evaluate the incidence and risk factors of pneumothoraces requiring prolonged maintenance of a chest tube following CT-guided percutaneous lung biopsy in a retrospective, single-centre case series. Materials and methods All patients undergoing CT-guided percutaneous lung biopsies between June 2012 and May 2014 who required chest tube insertion for symptomatic or enlarging pneumothoraces were identified. Based on chest tube dwell time, patients were divided into two groups: short term (0-2 days) or prolonged (3 or more days). The following risk factors were stratified between groups: patient demographics, target lesion characteristics, and procedural/ periprocedural technique and outcomes. Results A total of 2337 patients underwent lung biopsy; 543 developed pneumothorax (23.2 %), 187 required chest tube placement (8.0 %), and 55 required a chest tube for 3 days or more (2.9 % of all biopsies, 29.9 % of all chest tubes). The median chest tube dwell time for short-term and prolonged groups was 1.0 days and 4.7 days, respectively. The transfissural needle path predicted prolonged chest tube requirement (OR: 2.5; p = 0.023). Other factors were not significantly different between groups. Conclusion Of patients undergoing CT-guided lung biopsy, 2.9 % required a chest tube for 3 or more days. Transfissural needle path during biopsy was a risk factor for prolonged chest tube requirement. Key Points • CT-guided percutaneous lung biopsy (CPLB) is an important method for diagnosing lung lesions • A total of 2.9 % of patients require a chest tube for ≥3 days following CPLB • Transfissural needle path is a risk factor for prolonged chest tube time
Introduction
CT-guided percutaneous lung biopsy (CPLB) provides accurate diagnosis of lung lesions with a sensitivity of 67-94 % and specificity of 100 % [1] [2] [3] [4] [5] . Some studies indicate that core biopsies provide a more accurate diagnosis than fine-needle aspiration (FNA) [3] while others suggest that a combination of FNA and core biopsy specimens maximises the likelihood of providing a diagnostic specimen in a given patient [6, 7] . In light of its high diagnostic value with either strategy, CPLB is a common procedure in the clinical workup of concerning lung lesions-especially those that are inaccessible by transbronchial methods.
The most common complication after percutaneous lung biopsy is pneumothorax (incidence: 24-60 %) [5, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] , followed by pulmonary haemorrhage (incidence: 0-15 %) [8, 9, 19] . In light of the frequency at which pneumothorax occurs following CPLB, optimising its management is an important goal in quality improvement. All-cause iatrogenic pneumothorax is associated with an estimated additional $17,000 in cost of care and 4 days' length of hospital stay [20] . The average cost of a lung biopsy with complications is approximately four times higher than a complication-free biopsy ($37,745 vs. $8,869) [21] based on a cost analysis performed in the USA, with the conclusion that complicated biopsies are more expensive likely being generalisable outside the USA as well. Among the patients whose course is complicated by pneumothorax following CPLB, 5-53 % require placement of a chest tube to assist resolution [5, [12] [13] [14] [15] [16] [17] [18] . At most centres, the chest tube is a small-calibre (8 to 14 French) all-purpose drainage catheter attached to water seal or continuous suction, requiring inpatient management.
Observations from clinical practice have taught us that the majority of chest tubes can be removed within the first 2 days after placement (by post-CPLB day 2). The focus of the present study is on cases requiring prolonged chest tube dwell time. Existing studies have shown that 24-47 % of chest tubes require prolonged maintenance (arbitrarily defined as 3 or more days) [8, 10, 11] and that this subgroup of patients more frequently need secondary interventions (i.e. chest tube reinsertion or upsizing) [10] .
The purpose of the present study was to define the incidence and risk factors for chest tube requirement of 3 days or longer following CPLB toward the goal of better predicting these more protracted and complicated courses.
Materials and methods

Data collection
Our Institutional Review Board granted exemption to this retrospective case review. All protected health information was kept in a secure database compliant with the Health Insurance Portability and Accountability Act. A total of 2337 CT-guided percutaneous lung biopsies were performed at our centre during the inclusion period of June 2012 through May 2014 and included in the analysis.
Biopsy technique
Biopsies were performed by 1 of 15 board-certified interventional radiologists experienced in CPLB. Midazolam and fentanyl or meperidine alone was used for moderate sedation. Conventional CT or CT fluoroscopy was used for guidance. In patients with underlying emphysema/ COPD, a needle path that did not traverse any blebs or bullae was always selected. Either coaxial or bare needle biopsy techniques were used based on operator preference, although the vast majority of cases were performed with the coaxial technique. When a case required FNA samples alone, a bare needle technique was used in some instances. Coaxial biopsies were generally done with 17-or 19-gauge introducer needles. When required, core biopsy samples were always obtained with the coaxial technique using an 18-or 20-gauge semiautomatic core needle. FNA biopsies employed 20-or 22-gauge Wescott needles. A cytotechnologist performed immediate cytological assessment of all acquired samples to determine the preliminary sample adequacy for diagnosis. Repeat biopsy was performed within the same procedure session until a presumed adequate sample was obtained, until the operator determined that additional material was unlikely to aid diagnosis, or until the procedure was terminated because of haemorrhage or urgent need for chest tube placement. Two out of 15 operators employed the bloodpatching technique at their discretion.
Post-biopsy management
The interventional radiology service takes over the primary decision-making surrounding chest tube management in every patient at our institution. The decision to place a chest tube was made by a consensus of at least two interventional radiologists, and the placement was done by the first available physician to expedite care. Rarely, immediate large or symptomatic pneumothorax necessitated urgent placement of the chest tube during the initial biopsy procedure. For the vast majority of cases in which urgent chest tube placement was not required, chest x-rays were performed immediately post biopsy and 2 h later to evaluate for the presence of pneumothorax following the monitoring and imaging protocol described by Brown et al. [22] . Patients with no pneumothorax or stable asymptomatic pneumothorax on chest x-ray were discharged home with no further intervention. Patients with symptomatic (chest pain or dyspnoea), enlarging, or circumferential pneumothorax underwent chest tube placement ( 8. 5 -1 2 -F r e n c h a l l -p u r p os e dr a i n ag e ca t h e t e r ) . Fluoroscopy was used for imaging guidance and patients again received moderate sedation. Chest tubes were placed either on water seal or suction (in the case of large air leaks, persistent pneumothorax on water seal, or per operator preference). Patients were observed (and admitted at the discretion of the operator) until resolution of pneumothorax on serial chest x-rays and successful removal of the chest tube after a tube-clamping trial. The protocol for chest tube management at our institution is as follows: Once no air leak is evident and chest x-ray shows minimal or no pneumothorax we progress from suction (if used) to water seal, followed by a clamping trial, during which the catheter is closed via a three-way stopcock for a minimum of 1 h. If a chest x-ray at the end of the clamping trial is unchanged, the tube is removed. Decision for removal is achieved by consensus of at least two interventional radiologists at morning rounds. Patients with persistent air leak or malfunctioning/ misplaced chest tubes underwent exchange or upsizing of the tube in a second procedure.
Data collection
A registered, prospective institutional database of all CTguided lung biopsies performed in a 2-year period from June 2012 through May 2014 includes the following data: patient demographics, operator, needle gauge, number of specimens, and date of chest tube placement. We reviewed all cases within this database to identify the subset of patients who received a chest tube for management of iatrogenic pneumothorax as the study group of interest. Patient charts, intra-procedural CT images, and post-procedural chest x-rays were retrospectively reviewed for all study group patients. Data collection included patient variables (sex, age, documented clinical diagnosis of emphysema/COPD), target variables [maximum axial diameter, laterality, lobe, prior ipsilateral chest intervention (including biopsy, ablation, surgery, or radiation), distance from the nearest pleural surface (zero indicating a pleural-based lesion), and pathology reports]; procedural variables (coaxial versus non-coaxial technique, FNA only vs. core ± FNA, largest needle size used, patient position, length of procedure, path of the needle, and number of pleural interface punctures); and clinical course of the pneumothorax and its management (pneumothorax size, chest tube size, presence of air leak, and chest tube dwell time). In counting pleural interface punctures, one puncture was counted for each passage of a needle either (1) percutaneously through parietal and into visceral pleura to enter the lung parenchyma or (2) through two layers of visceral pleura to cross a fissure. One of three designations was assigned to describe the needle path: An intraparenchymal needle path passed through no lung fissures, a transfissural needle path passed through at least one major or minor fissure, and a superficial needle path had a shallow trajectory, passing just below (within 2 cm of) the pleural surface for its entirety. Chest tube dwell time was assigned on the basis of the interval between procedure note timestamps from chest tube insertion and removal. Although a total of 190 chest tubes were recorded in the database, 3 cases were excluded. Two cases were excluded from analysis because of a thermal ablation procedure done during the same session, and one case was excluded because a chest tube was placed for pre-existing empyema rather than for post-CTLB pneumothorax.
Statistical analysis
Univariate statistical analyses were performed using Prism version 6.00 (GraphPad Software, La Jolla CA, USA). Descriptive statistics were represented as mean ± SD. Categorical variables were compared using Fisher exact or chi-square tests. Continuous variables were analysed using Mann-Whitney or Kruskal-Wallis one-way analysis of variance. For variables that reached significance, odd ratios and confidence intervals were computed using two- 
Results
Incidence analysis
Among the 2337 patients on whom CT-guided percutaneous lung biopsy was performed during the study period, 543 developed post-procedural pneumothorax visible on chest x-ray (23.2 %). A total of 187 patients required chest tube placement (8.0 % of all biopsies and 34.4 % of all pneumothoraces), and 55 required a chest tube for 3 days or more (2.9 % of all biopsies, 10.1 % of all pneumothoraces, and 29.4 % of all chest tubes) (Fig. 1) . The median dwell times of chest tubes for the short-term and prolonged groups were 1.0 days (range: 0.2-2.0) and 4.7 days (range: 3.0-13.8), respectively.
Demographic risk factors for prolonged chest tube requirement
A demographic comparison of patients requiring short-term versus prolonged chest tube dwell times is summarised in Table 1 . Age, sex, history of prior ipsilateral lung interventions, history of smoking, and underlying clinical diagnoses of emphysema/COPD were not significantly different between the two groups. 
Target-related risk factors for prolonged chest tube requirement
A comparison of target lesion features between patients requiring short-term versus prolonged chest tube dwell time is summarised in Table 2 . Lesion diameter, laterality, lobe, and distance from pleura were similar between both groups. The rates of non-diagnostic versus benign versus malignant findings on pathologic assessment were not significantly different between the two groups. Considering malignant lesions only, there was no significant difference in the rate at which pathologic features suggestive of metastatic origin were present between the two groups. Among presumed primary lung malignancies, there was no difference in the rate of tumour subtypes between short-term and prolonged chest tube groups.
Procedural/periprocedural risk factors for prolonged chest tube requirement Table 3 compares the technical approach and immediate-post procedure outcomes between patients requiring short-term and prolonged chest tubes. There was no significant difference between groups for the following aspects of the procedure: coaxial versus non-coaxial technique, core biopsy ± FNA vs. FNA alone, largest needle gauge used, number of punctures through a pleural interface, or patient positioning. Procedure duration was longer on average among cases resulting in prolonged chest tube dwell time, but this trend did not reach statistical significance (p = 0.051). Needle path, however, did prove to be a significant risk factor for prolonged chest tube requirement (p = 0.039 for contingency analysis comparing all three needle path types), with a transfissural needle approach conferring higher risk than an intraparenchymal approach (Figs. 2 and  3 , p = 0.038 for head-to-head contingency analysis between these two needle path types). No significant difference was found for a superficial approach versus intraparenchymal or transfissural approach. When biopsy results in chest tube placement, the odds of having a chest tube placed for greater than 3 days is 2.5 times higher for transfissural biopsies than for intraparenchymal biopsies (95 % CI = 1.14 -5.31; p = 0.023, Fisher exact test).
Among post-biopsy monitoring parameters, initial size of the pneumothorax, size of the chest tube placed, and documented air leak did not prove to be predictive of a short versus prolonged requirement for a chest tube.
Discussion
In the era of personalised medicine, it is increasingly critical to have accurate information regarding the cell type and genetic/ Immediate post biopsy CT fluoroscopic image demonstrates a small anterior pneumothorax. The needle tract is indicated with a dotted arrow. This patient ultimately required a chest tube for just over 3 days molecular composition of a given tumour. For example, while all non-small cell lung cancers were once treated in a similar fashion, this is no longer the case. Several studies have shown that tumour subtype and gene mutations can influence the response to different treatments [23] [24] [25] [26] [27] [28] [29] .
CPLB is commonly used to provide safe and accurate diagnosis of lung lesions. Though CPLB is generally well tolerated, complications of CPLB include pneumothorax, pulmonary haemorrhage (haemoptysis and haemothorax), air embolism, tumour seeding, and infection [19, 30] . Pneumothorax and pulmonary haemorrhage occur most commonly, while other complications are rare [19] . The reported frequency of pneumothorax after CPLB ranges from 24 % to 60 % [5, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] ]. In the current study, the rate of pneumothorax was 23 %-consistent with previous reports.
A body of literature has sought to identify risk factors for developing pneumothorax after CPLB, as well as risk factors for pneumothorax necessitating chest tube placement after CPLB. The key, large studies on this subject and the risk factors identified are outlined in Table 4 . While the natural history of CPLB-associated pneumothorax is such that most resolve rapidly after chest tube placement, a subset are refractory, requiring prolonged chest tube dwell time [8, 10, 11] . Cases requiring prolonged chest tube maintenance can cause extended discomfort for patients and consume more resources within health care systems.
The present study represents the largest published series to date (n = 56) focussing on patients requiring prolonged chest tube dwell time after CPLB. The incidence of prolonged chest tube requirement (≥3 days) after CPLB has been estimated at 24-47 % of patients who had chest tubes placed [8, 10, 11] . The current study reports a similar incidence of 29 %.
In terms of non-modifiable patient and target-related predictors for prolonged chest tube dwell time, emphysematous parenchyma along the needle tract is the only previously published risk factor [10] . The mechanism proposed to explain this phenomenon is that obstructive pulmonary disease is associated with increased airway pressures, which may prevent tissue along needle tracts from re-apposing-thereby holding open a passage for persistent air leak. Emphysema was evaluated as a risk factor in the present study based on imaging findings of emphysema, plus emphysema/COPD as a documented patient diagnosis. Per institutional protocol, in no case did the needle tract pass through a bulla or bleb, and this was verified on imaging review of the needle path in each case. Although our data do not corroborate the findings of Gupta et al. supporting emphysema as a risk factor for prolonged chest tube dwell time, this may be in part due to a relative underrepresentation of emphysema/COPD patients in our patient population (coming from an academic cancer centre as opposed to the general population). While underlying emphysema/COPD does not represent a modifiable risk factor for prolonged chest tube dwell time, considering emphysema/ COPD diagnosis in risk-stratifying patients before electing to pursue CPLB may aid both patients and operators in the informed consent process. A transfissural (as opposed to intraparenchymal or superficial) needle path represents a potentially modifiable risk factor for developing a prolonged chest tube requirement identified in this study. Gupta et al. did evaluate the number of punctures of the visceral pleura as a predictor of prolonged chest tube dwell time, but did not find it to be significant [10] . There is a reasonable corollary in the literature on post-CPLB pneumothorax in general [13, 14] , however, to suggest that a transfissural needle path may predispose a patient to air leak following lung biopsy-with the hypothesis behind this phenomenon being that multiple pleural punctures leave multiple opportunities for air leak. The mechanism may also be in part from shearing at the punctures along a fissure as each lobe slides somewhat independently from the other with breathing and the needle is fixed within each of them. At a pleural puncture along the chest wall, the needle can move freely with the lung if it's in just one lobe, fixed with the chest wall as its pivot point-this might allow for less pleural tearing than occurs at the interface between two lobes for a transfissural puncture. These unique mechanical forces along transfissural punctures may explain in part why a non-stratified analysis of the number of all-type (including non-transfissural) pleural punctures was not significantly different between the shortterm and prolonged chest tube duration groups in this series. Based on our findings in this series, it seems that if a reasonable alternative is available, an operator might try to avoid a transfissural needle trajectory during CPLB.
One negative result from this study is especially notable: the presence or absence of documented air leak was not found to be an indicator of a requirement for a prolonged chest tube in this series. The bedside method for assessing air leak (as signified by bubbles through the water chamber) used in clinical practice today is evidently not sensitive enough to capture all cases of clinically significant air leak.
This study was subject to several limitations, including its retrospective design, as well as its caseload and practice patterns specific to an academic cancer centre. Of note, whether the blood-patching technique was employed usually was not documented and therefore could not be accurately analysed retrospectively. Only 2 out of 15 operators used the blood patch technique for approximately half of their patients. While the operator-specific pneumothorax rate was not calculated for this study, the pneumothorax rate was not found to be significantly different amongst the 15 operators based on internal quality assurance data. The two operators who employ the blood-patching technique have individual chest tube rates as documented for institutional quality improvement data that are not significantly different from other operators in the group. For this reason we do not believe that the blood patch technique was likely to have predicted outcomes in this study. Additionally, as previously mentioned, this study did not evaluate patient CT scans for the presence and grade of emphysematous changes along needle tracts.
In conclusion, pneumothorax is known to be the most common complication of CPLB. About 30 % of cases resulting in chest tube placement (2.9 % of total CPLB cases) require chest tube maintenance of 3 or more days. The present study shows that biopsy needle paths that cross the lung fissures may also increase this risk. Cases should be risk-stratified accordingly, and transfissural biopsy needle paths should be avoided if possible.
